Insufficient scRNA-seq data for expression of ISL2 at single-cell level.
Insufficient scRNA-seq data for expression of ISL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 93% | 113.15 | 1339 / 1445 | 77% | 1.87 | 141 / 183 |
stomach | 96% | 108.42 | 345 / 359 | 40% | 1.04 | 113 / 286 |
intestine | 99% | 116.88 | 958 / 966 | 31% | 0.66 | 166 / 527 |
prostate | 98% | 168.72 | 239 / 245 | 18% | 0.32 | 88 / 502 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.84 | 1 / 1 |
lymph node | 0% | 0 | 0 / 0 | 90% | 3.22 | 26 / 29 |
spleen | 89% | 43.56 | 214 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 80% | 81.10 | 746 / 929 | 0% | 0 | 0 / 0 |
bladder | 10% | 2.29 | 2 / 21 | 56% | 1.40 | 282 / 504 |
skin | 38% | 22.01 | 684 / 1809 | 21% | 1.07 | 101 / 472 |
lung | 26% | 6.43 | 151 / 578 | 32% | 0.73 | 365 / 1155 |
uterus | 2% | 2.40 | 3 / 170 | 53% | 2.08 | 244 / 459 |
tonsil | 0% | 0 | 0 / 0 | 51% | 1.27 | 23 / 45 |
adrenal gland | 2% | 0.91 | 6 / 258 | 34% | 2.69 | 78 / 230 |
adipose | 36% | 19.49 | 435 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 2% | 0.45 | 7 / 328 | 31% | 0.58 | 55 / 178 |
brain | 3% | 0.86 | 74 / 2642 | 27% | 1.07 | 191 / 705 |
liver | 0% | 0 | 0 / 226 | 14% | 0.33 | 55 / 406 |
breast | 2% | 0.81 | 8 / 459 | 5% | 0.14 | 60 / 1118 |
thymus | 4% | 1.39 | 27 / 653 | 0% | 0.02 | 3 / 605 |
ovary | 0% | 0 | 0 / 180 | 3% | 0.06 | 15 / 430 |
kidney | 2% | 0.49 | 2 / 89 | 1% | 0.04 | 10 / 901 |
eye | 0% | 0 | 0 / 0 | 1% | 0.04 | 1 / 80 |
blood vessel | 1% | 0.28 | 10 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007409 | Biological process | axonogenesis |
GO_0021520 | Biological process | spinal cord motor neuron cell fate specification |
GO_0048665 | Biological process | neuron fate specification |
GO_0045665 | Biological process | negative regulation of neuron differentiation |
GO_0021524 | Biological process | visceral motor neuron differentiation |
GO_0031290 | Biological process | retinal ganglion cell axon guidance |
GO_0048935 | Biological process | peripheral nervous system neuron development |
GO_0048666 | Biological process | neuron development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ISL2 |
Protein name | Insulin gene enhancer protein ISL-2 (Islet-2) ISL LIM homeobox 2 Insulin gene enhancer protein ISL-2 |
Synonyms | |
Description | FUNCTION: Transcriptional factor that defines subclasses of motoneurons that segregate into columns in the spinal cord and select distinct axon pathways. . |
Accessions | H0YN25 ENST00000290759.9 Q96A47 ENST00000558656.1 F1T0J9 |